| MeSH term | MeSH ID | Detail |
|---|---|---|
| Coronary Occlusion | D054059 | 4 associated lipids |
| Lung Injury | D055370 | 14 associated lipids |
| Hypertrophy | D006984 | 16 associated lipids |
| Pre-Eclampsia | D011225 | 16 associated lipids |
| Hyperemia | D006940 | 25 associated lipids |
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
14,15-eet
14,15-eet is a lipid of Fatty Acyls (FA) class. 14,15-eet is associated with abnormalities such as Heart failure, Chronic Obstructive Airway Disease, Pneumonia and Fatty Liver. The involved functions are known as chromophore, Stereochemistry, Cell Respiration, cell transformation and oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen. 14,15-eet often locates in Lambda, Cardiovascular system, Blood, Body tissue and Protoplasm. The associated genes with 14,15-eet are CCL2 gene, Cytokine Gene, CYP2C18 gene, CYP2C19 gene and TEK gene. The related lipids are Palmitates.
Cross Reference
Introduction
To understand associated biological information of 14,15-eet, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 14,15-eet?
14,15-eet is suspected in Heart failure, Chronic Obstructive Airway Disease, Pneumonia, Fatty Liver and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Am. J. Physiol. Endocrinol. Metab. (1)
- Am. J. Physiol. Lung Cell Mol. Physiol. (1)
- Prostaglandins Other Lipid Mediat. (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 14,15-eet
PubChem Associated disorders and diseases
What pathways are associated with 14,15-eet
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 14,15-eet?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Am. J. Physiol. Lung Cell Mol. Physiol. (2)
- Am. J. Physiol. Endocrinol. Metab. (1)
- Hypertension (1)
- Others (2)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 14,15-eet?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 14,15-eet?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 14,15-eet?
Related references are published most in these journals:
- Am. J. Physiol. Endocrinol. Metab. (1)
- Am. J. Physiol. Lung Cell Mol. Physiol. (1)
- Hypertension (1)
- Others (1)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 14,15-eet?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 14,15-eet
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lamb DC et al. | Streptomyces coelicolor A3(2) CYP102 protein, a novel fatty acid hydroxylase encoded as a heme domain without an N-terminal redox partner. | 2010 | Appl. Environ. Microbiol. | pmid:20097805 |
| Dunn LK et al. | Chick chorioallantoic membrane as an in vivo model to study vasoreactivity: characterization of development-dependent hyperemia induced by epoxyeicosatrienoic acids (EETs). | 2005 | Anat Rec A Discov Mol Cell Evol Biol | pmid:15952186 |
| Hammonds TD et al. | Resolution of epoxyeicosatrienoate enantiomers by chiral phase chromatography. | 1989 | Anal. Biochem. | pmid:2610347 |
| Nithipatikom K et al. | Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. | 2001 | Anal. Biochem. | pmid:11319825 |
| Nithipatikom K et al. | Determination of 14,15-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid by fluoroimmunoassay. | 1997 | Anal. Biochem. | pmid:9073364 |
| Wei S et al. | Chiral resolution of the epoxyeicosatrienoic acids, arachidonic acid epoxygenase metabolites. | 2006 | Anal. Biochem. | pmid:16480681 |
| Schebb NH et al. | Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors. | 2011 | Anal Bioanal Chem | pmid:21479549 |
| Alvarez DF et al. | Resistance to store depletion-induced endothelial injury in rat lung after chronic heart failure. | 2005 | Am. J. Respir. Crit. Care Med. | pmid:16051904 |
| Morin C et al. | Epoxyeicosatrienoic acid relaxing effects involve Ca2+-activated K+ channel activation and CPI-17 dephosphorylation in human bronchi. | 2007 | Am. J. Respir. Cell Mol. Biol. | pmid:17237191 |
| Morin C et al. | 17,18-epoxyeicosatetraenoic acid targets PPARγ and p38 mitogen-activated protein kinase to mediate its anti-inflammatory effects in the lung: role of soluble epoxide hydrolase. | 2010 | Am. J. Respir. Cell Mol. Biol. | pmid:20008283 |
| Morin C et al. | CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi. | 2008 | Am. J. Respir. Cell Mol. Biol. | pmid:18757304 |
| Morin C et al. | EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17. | 2008 | Am. J. Respir. Cell Mol. Biol. | pmid:17872494 |
| Salvail D et al. | Functional reconstitution of an eicosanoid-modulated Cl- channel from bovine tracheal smooth muscle. | 2002 | Am. J. Physiol., Cell Physiol. | pmid:11832342 |
| Pavlov TS et al. | Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC). | 2011 | Am. J. Physiol. Renal Physiol. | pmid:21697242 |
| Gauthier KM et al. | Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles. | 2011 | Am. J. Physiol. Renal Physiol. | pmid:21753077 |
| Li Y et al. | 14,15-Epoxyeicosatrienoic acid suppresses cigarette smoke condensate-induced inflammation in lung epithelial cells by inhibiting autophagy. | 2016 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:27591243 |
| Kandhi S et al. | EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase. | 2015 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:26498250 |
| Tabet Y et al. | Relationship between bradykinin-induced relaxation and endogenous epoxyeicosanoid synthesis in human bronchi. | 2013 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:23418089 |
| Benoit C et al. | EETs relax airway smooth muscle via an EpDHF effect: BK(Ca) channel activation and hyperpolarization. | 2001 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:11290521 |
| Senouvo FY et al. | Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi. | 2011 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:21821730 |
| Zhu D et al. | Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries. | 2000 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:10666118 |
| Alvarez DF et al. | Role of EETs in regulation of endothelial permeability in rat lung. | 2004 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:14578116 |
| Ye D et al. | Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid. | 2006 | Am. J. Physiol. Heart Circ. Physiol. | pmid:16537788 |
| Sacerdoti D et al. | Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase. | 2006 | Am. J. Physiol. Heart Circ. Physiol. | pmid:16798831 |
| Campbell WB et al. | Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase. | 2006 | Am. J. Physiol. Heart Circ. Physiol. | pmid:16143653 |
| Motoki A et al. | Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. | 2008 | Am. J. Physiol. Heart Circ. Physiol. | pmid:18835921 |
| Pratt PF et al. | Endothelium-independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs. | 2001 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11179054 |
| Gross GJ et al. | Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts. | 2010 | Am. J. Physiol. Heart Circ. Physiol. | pmid:20400686 |
| Merkel MJ et al. | Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling. | 2010 | Am. J. Physiol. Heart Circ. Physiol. | pmid:20008276 |
| Miller AW et al. | Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance. | 2001 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11557540 |
| Zhang Y et al. | EET homologs potently dilate coronary microvessels and activate BK(Ca) channels. | 2001 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11356595 |
| Rastaldo R et al. | Cytochrome P-450 metabolite of arachidonic acid mediates bradykinin-induced negative inotropic effect. | 2001 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11356641 |
| Ye D et al. | Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid. | 2005 | Am. J. Physiol. Heart Circ. Physiol. | pmid:15331373 |
| Campbell WB et al. | 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:11959628 |
| Snyder GD et al. | Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:12384472 |
| Falck JR et al. | Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation. | 2003 | Am. J. Physiol. Heart Circ. Physiol. | pmid:12388250 |
| Medhora M et al. | Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. | 2003 | Am. J. Physiol. Heart Circ. Physiol. | pmid:12388259 |
| Fang X et al. | Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide. | 2002 | Am. J. Physiol. Heart Circ. Physiol. | pmid:12388281 |
| Nithipatikom K et al. | Determination of EETs using microbore liquid chromatography with fluorescence detection. | 2000 | Am. J. Physiol. Heart Circ. Physiol. | pmid:10924087 |
| Gross GJ et al. | Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart. | 2008 | Am. J. Physiol. Heart Circ. Physiol. | pmid:18441205 |
| Gauthier KM et al. | Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries. | 2005 | Am. J. Physiol. Heart Circ. Physiol. | pmid:15528233 |
| Fang X et al. | 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. | 2006 | Am. J. Physiol. Heart Circ. Physiol. | pmid:16113065 |
| Fang X et al. | Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. | 2004 | Am. J. Physiol. Heart Circ. Physiol. | pmid:15284062 |
| Chadderdon SM et al. | Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates. | 2012 | Am. J. Physiol. Endocrinol. Metab. | pmid:22739105 |
| Chen G et al. | CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice. | 2015 | Am. J. Physiol. Endocrinol. Metab. | pmid:25389366 |
| Leffler CW and Fedinec AL | Newborn piglet cerebral microvascular responses to epoxyeicosatrienoic acids. | 1997 | Am. J. Physiol. | pmid:9249508 |
| Ma YH et al. | Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. | 1994 | Am. J. Physiol. | pmid:8067471 |
| Snyder GD et al. | Effect of epoxyeicosatrienoic acids on growth hormone release from somatotrophs. | 1989 | Am. J. Physiol. | pmid:2563927 |
| Schlondorff D et al. | Epoxygenase metabolites of arachidonic acid inhibit vasopressin response in toad bladder. | 1987 | Am. J. Physiol. | pmid:2820243 |
| Zou AP et al. | Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity. | 1996 | Am. J. Physiol. | pmid:8928844 |